Back to search
FDAFDA · Food and drugs·Recall number D-0484-2025

Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112

Published July 2, 2025 · Recall initiated: May 21, 2025

Summary

FDA records drug Class II recall D-0484-2025, published July 2, 2025 and initiated May 21, 2025. Recalling firm: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado); Status: Ongoing; Reported quantity: 4 syringes; Lot: Lot: H388348. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
Distributor
USA Nationwide
Lot
Lot: H388348
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 recalled?

Yes. FDA published recall D-0484-2025 on July 2, 2025. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail